JP4592326B2 - Patch - Google Patents
Patch Download PDFInfo
- Publication number
- JP4592326B2 JP4592326B2 JP2004134121A JP2004134121A JP4592326B2 JP 4592326 B2 JP4592326 B2 JP 4592326B2 JP 2004134121 A JP2004134121 A JP 2004134121A JP 2004134121 A JP2004134121 A JP 2004134121A JP 4592326 B2 JP4592326 B2 JP 4592326B2
- Authority
- JP
- Japan
- Prior art keywords
- patch
- adhesive
- adhesive base
- acid
- glucan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000853 adhesive Substances 0.000 claims description 93
- 230000001070 adhesive effect Effects 0.000 claims description 93
- 229920002498 Beta-glucan Polymers 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 229920002125 Sokalan® Polymers 0.000 claims description 11
- 239000010410 layer Substances 0.000 claims description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
- 239000004584 polyacrylic acid Substances 0.000 claims description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
- 239000003522 acrylic cement Substances 0.000 claims description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 239000001879 Curdlan Substances 0.000 claims description 5
- 229920002558 Curdlan Polymers 0.000 claims description 5
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 239000001913 cellulose Substances 0.000 claims description 5
- 235000019316 curdlan Nutrition 0.000 claims description 5
- 229940078035 curdlan Drugs 0.000 claims description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 5
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 229920001400 block copolymer Polymers 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 229920005615 natural polymer Polymers 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 claims description 2
- 239000007857 degradation product Substances 0.000 claims 1
- 239000002585 base Substances 0.000 description 52
- -1 alkali metal alginate Chemical class 0.000 description 29
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- 229920001577 copolymer Polymers 0.000 description 13
- 239000011505 plaster Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 10
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical group CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 239000012790 adhesive layer Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 6
- 229920006132 styrene block copolymer Polymers 0.000 description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940105329 carboxymethylcellulose Drugs 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 5
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 4
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229940022663 acetate Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000011256 inorganic filler Substances 0.000 description 3
- 229910003475 inorganic filler Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000010734 process oil Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 3
- SERLAGPUMNYUCK-URHLDCCQSA-N (2R,3S,4R,5S)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-URHLDCCQSA-N 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 239000013032 Hydrocarbon resin Substances 0.000 description 2
- 229920001755 Kefiran Polymers 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 229960002389 glycol salicylate Drugs 0.000 description 2
- 229920006270 hydrocarbon resin Polymers 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 2
- 229960001454 nitrazepam Drugs 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001289 polyvinyl ether Polymers 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- SWFHGTMLYIBPPA-UHFFFAOYSA-N (4-methoxyphenyl)-phenylmethanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 SWFHGTMLYIBPPA-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- OTJFQRMIRKXXRS-UHFFFAOYSA-N (hydroxymethylamino)methanol Chemical compound OCNCO OTJFQRMIRKXXRS-UHFFFAOYSA-N 0.000 description 1
- BFUXUGOZJVHVMR-UHFFFAOYSA-N 1,1-dioxo-3,4-dihydro-2h-1$l^{6},2,4-benzothiadiazine-7-sulfonamide Chemical compound N1CNS(=O)(=O)C2=CC(S(=O)(=O)N)=CC=C21 BFUXUGOZJVHVMR-UHFFFAOYSA-N 0.000 description 1
- SQUNAWUMZGQQJD-UHFFFAOYSA-N 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one Chemical compound C1=CC(CC)=CC=C1C(=O)C(C)CN1CCCCC1 SQUNAWUMZGQQJD-UHFFFAOYSA-N 0.000 description 1
- OZOMQRBLCMDCEG-CHHVJCJISA-N 1-[(z)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(O1)=CC=C1\C=N/N1C(=O)NC(=O)C1 OZOMQRBLCMDCEG-CHHVJCJISA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LVOGXJMCDAOKSQ-UHFFFAOYSA-N 10-oxo-10-propan-2-yloxydecanoic acid Chemical compound CC(C)OC(=O)CCCCCCCCC(O)=O LVOGXJMCDAOKSQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- CRFFPDBJLGAGQL-UHFFFAOYSA-N 2-azaniumyl-3-[4-(trifluoromethyl)phenyl]propanoate Chemical compound OC(=O)C(N)CC1=CC=C(C(F)(F)F)C=C1 CRFFPDBJLGAGQL-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UYNVMODNBIQBMV-UHFFFAOYSA-N 4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol Chemical compound C1CC(CC=2C=CC=CC=2)CCN1C(C)C(O)C1=CC=C(O)C=C1 UYNVMODNBIQBMV-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- FGBFEFJZYZDLSZ-UHFFFAOYSA-N 5,7-dimethoxy-2,3-dimethyl-2,3-dihydroinden-1-one Chemical compound COC1=CC(OC)=CC2=C1C(=O)C(C)C2C FGBFEFJZYZDLSZ-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- MKBLHFILKIKSQM-UHFFFAOYSA-N 9-methyl-3-[(2-methyl-1h-imidazol-3-ium-3-yl)methyl]-2,3-dihydro-1h-carbazol-4-one;chloride Chemical compound Cl.CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 MKBLHFILKIKSQM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- KFYRPLNVJVHZGT-UHFFFAOYSA-N Amitriptyline hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KFYRPLNVJVHZGT-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- IROWCYIEJAOFOW-UHFFFAOYSA-N DL-Isoprenaline hydrochloride Chemical compound Cl.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 IROWCYIEJAOFOW-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- LVHOURKCKUYIGK-RGUJTQARSA-N Dimethisterone Chemical compound C1([C@@H](C)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C#CC)(O)[C@@]2(C)CC1 LVHOURKCKUYIGK-RGUJTQARSA-N 0.000 description 1
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- WUKZPHOXUVCQOR-UHFFFAOYSA-N N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide Chemical compound C1N(CC2)CCC2C1NC(=O)C1=CC(Cl)=CC2=C1OCC(=O)N2C WUKZPHOXUVCQOR-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- IMONTRJLAWHYGT-ZCPXKWAGSA-N Norethindrone Acetate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 IMONTRJLAWHYGT-ZCPXKWAGSA-N 0.000 description 1
- APTGJECXMIKIET-WOSSHHRXSA-N Norethindrone enanthate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)CCCCCC)[C@@]1(C)CC2 APTGJECXMIKIET-WOSSHHRXSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 241001296405 Tiso Species 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- RSLNRVYIRDVHLY-UHFFFAOYSA-N Tulobuterol hydrochloride Chemical compound [Cl-].CC(C)(C)[NH2+]CC(O)C1=CC=CC=C1Cl RSLNRVYIRDVHLY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- YWXYYJSYQOXTPL-JGWLITMVSA-N [(3r,3ar,6s,6as)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-JGWLITMVSA-N 0.000 description 1
- ITBPIKUGMIZTJR-UHFFFAOYSA-N [bis(hydroxymethyl)amino]methanol Chemical compound OCN(CO)CO ITBPIKUGMIZTJR-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229960002692 allylestrenol Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 229920003180 amino resin Polymers 0.000 description 1
- 229960005119 amitriptyline hydrochloride Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940125688 antiparkinson agent Drugs 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003920 antivertigo agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 description 1
- 229960005207 auranofin Drugs 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 229950005951 azasetron Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940047187 benzoresorcinol Drugs 0.000 description 1
- 239000001518 benzyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- NGHOLYJTSCBCGC-QXMHVHEDSA-N benzyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-QXMHVHEDSA-N 0.000 description 1
- UUQMNUMQCIQDMZ-UHFFFAOYSA-N betahistine Chemical compound CNCCC1=CC=CC=N1 UUQMNUMQCIQDMZ-UHFFFAOYSA-N 0.000 description 1
- 229960004536 betahistine Drugs 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- ABBZJHFBQXYTLU-UHFFFAOYSA-N but-3-enamide Chemical compound NC(=O)CC=C ABBZJHFBQXYTLU-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- NGHOLYJTSCBCGC-UHFFFAOYSA-N cis-cinnamic acid benzyl ester Natural products C=1C=CC=CC=1C=CC(=O)OCC1=CC=CC=C1 NGHOLYJTSCBCGC-UHFFFAOYSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229960001564 clomipramine hydrochloride Drugs 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 229960001987 dantrolene Drugs 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229950006690 dimethisterone Drugs 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- OGAKLTJNUQRZJU-UHFFFAOYSA-N diphenidol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)CCCN1CCCCC1 OGAKLTJNUQRZJU-UHFFFAOYSA-N 0.000 description 1
- 229960003520 diphenidol Drugs 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- JGMOKGBVKVMRFX-HQZYFCCVSA-N dydrogesterone Chemical compound C1=CC2=CC(=O)CC[C@@]2(C)[C@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 JGMOKGBVKVMRFX-HQZYFCCVSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960002565 eperisone Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960000445 ethisterone Drugs 0.000 description 1
- CHNXZKVNWQUJIB-CEGNMAFCSA-N ethisterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 CHNXZKVNWQUJIB-CEGNMAFCSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- ONKUMRGIYFNPJW-KIEAKMPYSA-N ethynodiol diacetate Chemical compound C1C[C@]2(C)[C@@](C#C)(OC(C)=O)CC[C@H]2[C@@H]2CCC3=C[C@@H](OC(=O)C)CC[C@@H]3[C@H]21 ONKUMRGIYFNPJW-KIEAKMPYSA-N 0.000 description 1
- 229960000218 etynodiol Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229960002690 fluphenazine Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 229960003607 granisetron hydrochloride Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- DMDGGSIALPNSEE-UHFFFAOYSA-N hydroflumethiazide Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O DMDGGSIALPNSEE-UHFFFAOYSA-N 0.000 description 1
- 229960003313 hydroflumethiazide Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- QYZRTBKYBJRGJB-UHFFFAOYSA-N hydron;1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide;chloride Chemical compound Cl.C1=CC=C2C(C(=O)NC3CC4CCCC(C3)N4C)=NN(C)C2=C1 QYZRTBKYBJRGJB-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229960003998 ifenprodil Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 229960003988 indigo carmine Drugs 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229920003049 isoprene rubber Polymers 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940018448 isoproterenol hydrochloride Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 229960003630 ketotifen fumarate Drugs 0.000 description 1
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000005001 laminate film Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VKQFCGNPDRICFG-UHFFFAOYSA-N methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+]([O-])=O VKQFCGNPDRICFG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960000227 nisoldipine Drugs 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- ZAOCWQZQPKGTRN-UHFFFAOYSA-N nitrous acid;sodium Chemical compound [Na].ON=O ZAOCWQZQPKGTRN-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- 229960001652 norethindrone acetate Drugs 0.000 description 1
- 229960002082 norethindrone enanthate Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229950002083 octabenzone Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229960000770 ondansetron hydrochloride Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960005434 oxybutynin Drugs 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002742 polystyrene-block-poly(ethylene/propylene) -block-polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229950001588 ramosetron Drugs 0.000 description 1
- NTHPAPBPFQJABD-LLVKDONJSA-N ramosetron Chemical compound C12=CC=CC=C2N(C)C=C1C(=O)[C@H]1CC(NC=N2)=C2CC1 NTHPAPBPFQJABD-LLVKDONJSA-N 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960004846 tulobuterol hydrochloride Drugs 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229920006305 unsaturated polyester Polymers 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 229960001661 ursodiol Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Description
本発明は貼付剤に関する。 The present invention relates to a patch.
貼付剤は、医薬品としての外用剤、化粧品及び医薬部外品としてのパック剤等に用いられるほか、粘着性を有する包帯に至るまで幅広く用いられている。貼付剤は、粘着基剤中に水分を含有するもの(パップ剤等)と含有しないもの(プラスター剤等)とに大別することができる。粘着基剤中に水分を含有する貼付剤としては、ゼラチン系湿布剤や、ポリアクリル酸及びポリアクリル酸塩を含有し、更にカルボキシメチルセルロース及び/又はアルギン酸アルカリ金属塩を含有してなることを特徴とする非ゼラチン系湿布剤(特許文献1)などが知られている。
しかしながら、粘着基剤中に水分を含有する貼付剤は、粘着基剤中に水分を含有しない貼付剤(いわゆる、非水系貼付剤)と比べて、保湿性が高く使用感は優れているものの、粘着力が弱く、使用時に皮膚から剥がれ易いという問題点があった。したがって、本発明の目的は、使用感に優れ、かつ、充分な粘着力を有する貼付剤を提供することにある。 However, although a patch containing moisture in the adhesive base has higher moisturizing properties and superior usability compared to a patch that does not contain moisture in the adhesive base (so-called non-aqueous patch), There was a problem that the adhesive strength was weak and it was easily peeled off from the skin during use. Accordingly, an object of the present invention is to provide a patch having excellent usability and sufficient adhesive strength.
本発明者らは、上記目的を達成すべく鋭意研究を重ねた結果、粘着基剤にβ−グルカンを含有させることにより、粘着力に優れた貼付剤が得られることを見出し、本発明を完成するに至った。 As a result of intensive studies to achieve the above object, the present inventors have found that a patch having excellent adhesive strength can be obtained by adding β-glucan to the adhesive base, and the present invention has been completed. It came to do.
すなわち、本発明は、支持体と、当該支持体の少なくとも一方の面上に配置された粘着剤層と、を備える貼付剤であって、前記粘着剤層がβ−グルカンを含む粘着基剤から形成されることを特徴とする貼付剤を提供する。ここで、優れた粘着性を得る観点から、β−グルカンはβ−1,3−グルカンであることが好ましく、カードランであることがより好ましい。β−グルカンの優れた粘着性は、パップ剤等の粘着基剤中に水分を含有する貼付剤のみならず、プラスター剤等の粘着基剤中に水分を含有しない貼付剤においても発揮される。 That is, the present invention is a patch comprising a support and an adhesive layer disposed on at least one surface of the support, wherein the adhesive layer includes an adhesive base containing β-glucan. Provided is a patch characterized by being formed. Here, from the viewpoint of obtaining excellent adhesiveness, β-glucan is preferably β-1,3-glucan, and more preferably curdlan. The excellent adhesiveness of β-glucan is exhibited not only in a patch containing moisture in an adhesive base such as a patch, but also in a patch containing no moisture in an adhesive base such as a plaster.
また、粘着基剤をβ−グルカンを含有させることにより、粘着性が向上するばかりでなく、粘着基剤を軟らかくすることが可能である。粘着基剤が軟らかくなることにより、貼付剤は皮膚に密着し易くなり、動きの激しい関節付近に貼付した場合でも剥がれ難くなるという利点が生じる。さらに、粘着基剤に香料が含まれている場合には、β−グルカンは香料の香りを強くするという作用をも有する。 In addition, by including β-glucan in the adhesive base, not only the adhesiveness is improved, but the adhesive base can be softened. When the adhesive base becomes soft, the patch becomes easy to adhere to the skin, and there is an advantage that it is difficult to peel off even when it is applied near a joint where movement is intense. Furthermore, when the fragrance | flavor is contained in the adhesive base, (beta) -glucan also has the effect | action of strengthening the fragrance of a fragrance | flavor.
本発明は、また、前記粘着基剤が、天然高分子、セルロース系ポリマー及びその塩、アクリル系ポリマー及びその塩、並びに、ビニル系ポリマー及びその塩からなる群から選択される一種以上の水溶性高分子を更に含有していることを特徴とする前記貼付剤を提供する。粘着基剤がかかる水溶性高分子を含有していることにより、粘着性をより良好なものとすることが可能となる。 In the present invention, the adhesive base may be one or more water-soluble substances selected from the group consisting of natural polymers, cellulose polymers and salts thereof, acrylic polymers and salts thereof, and vinyl polymers and salts thereof. Provided is the patch, which further contains a polymer. When the adhesive base contains such a water-soluble polymer, the adhesiveness can be made better.
本発明は、また、前記粘着基剤が、ポリアクリル酸及びその塩、ポリビニルアルコール、ポリビニルピロリドン、ポリ−N−メチルビニルアセトアミド、カルボキシメチルセルロース及びその塩、ヒドロキシエチルセルロース、並びに、ヒドロキシプロピルセルロースからなる群から選択される一種以上の水溶性高分子を更に含有していることを特徴とする前記貼付剤を提供する。粘着基剤がかかる水溶性高分子を含有していることにより、粘着性をより良好なものとすることが可能となる。 In the present invention, the adhesive base is composed of polyacrylic acid and a salt thereof, polyvinyl alcohol, polyvinylpyrrolidone, poly-N-methylvinylacetamide, carboxymethylcellulose and a salt thereof, hydroxyethylcellulose, and hydroxypropylcellulose. The patch further comprises at least one water-soluble polymer selected from the group consisting of: When the adhesive base contains such a water-soluble polymer, the adhesiveness can be made better.
本発明は、また、粘着基剤全質量を基準として、0.1〜15質量%のβ−グルカンと、0.1〜40質量%のポリアクリル酸及び/又はその塩と、0.1〜20質量%のポリビニルアルコールと、を含有していることを特徴とする前記貼付剤を提供する。かかる組成を有する貼付剤は使用感及び粘着性に優れている。 The present invention also includes 0.1 to 15% by mass of β-glucan, 0.1 to 40% by mass of polyacrylic acid and / or a salt thereof, based on the total mass of the adhesive base, The adhesive patch containing 20% by mass of polyvinyl alcohol is provided. A patch having such a composition is excellent in feeling of use and adhesiveness.
本発明は、また、前記粘着基剤が、アクリル系粘着剤及び/又はブロック共重合体系粘着剤を更に含有していることを特徴とする前記貼付剤を提供する。かかるプラスター剤の粘着基剤にβ−グルカンを含有させることにより、プラスター剤の粘着性を向上させることが可能である。 The present invention also provides the patch, wherein the adhesive base further contains an acrylic adhesive and / or a block copolymer adhesive. By including β-glucan in the adhesive base of the plaster agent, it is possible to improve the adhesiveness of the plaster agent.
本発明は、さらに、前記粘着基剤が薬物を含有することを特徴とする上記貼付剤を提供する。粘着剤層に薬物(薬効成分)が含有されていることにより、薬効を発揮し、かつ使用感及び粘着性に優れた貼付剤とすることが可能である。 The present invention further provides the patch, wherein the adhesive base contains a drug. By containing a drug (medicinal component) in the pressure-sensitive adhesive layer, it is possible to obtain a patch exhibiting a medicinal effect and excellent in feeling of use and adhesiveness.
本発明の貼付剤は、粘着基剤にβ−グルカンが含有されていることにより、充分な粘着力を発揮することが可能である。 The adhesive patch of the present invention can exhibit sufficient adhesive strength when β-glucan is contained in the adhesive base.
以下、図面を参照して本発明の好適な実施形態について詳細に説明する。 DESCRIPTION OF EMBODIMENTS Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the drawings.
図1は、本発明の貼付剤の好適な一実施形態を示す斜視図である。図1において、貼付剤1は、支持体2と、支持体2上に配置された粘着剤層3と、粘着剤層3上の貼着された剥離シート4と、を備えるものである。
FIG. 1 is a perspective view showing a preferred embodiment of the patch of the present invention. In FIG. 1, a patch 1 includes a
本実施形態の貼付剤1が備える粘着剤層3は、β−グルカンを含む粘着基剤から形成されている。粘着基剤中にβ−グルカンを配合することにより、得られる貼付剤の粘着力が増加し、貼付剤が使用中に剥がれ落ちるといった問題点を解決することが可能となる。 The pressure-sensitive adhesive layer 3 provided in the patch 1 of the present embodiment is formed from a pressure-sensitive adhesive base containing β-glucan. By blending β-glucan in the adhesive base, the adhesive strength of the obtained patch increases, and it becomes possible to solve the problem that the adhesive peels off during use.
β−グルカンとしては、β−1,3−グルカン、β−1,4−グルカン、β−1,6−グルカンなどがあるが、充分な粘着力を有した貼付剤を得るという観点からは、β−1,3−グルカンが好ましく、中でもカードランが最も好ましい。また、適切な粘着力を発揮させるという観点から、β−グルカンの含有量は、粘着基剤全質量を基準として、0.1〜15質量%であることが好ましく、0.1〜5質量%であることがより好ましい。 As β-glucan, there are β-1,3-glucan, β-1,4-glucan, β-1,6-glucan, etc., from the viewpoint of obtaining a patch having sufficient adhesive force, β-1,3-glucan is preferred, with curdlan being most preferred. Moreover, from the viewpoint of exerting appropriate adhesive strength, the content of β-glucan is preferably 0.1 to 15% by mass, based on the total mass of the adhesive base, and 0.1 to 5% by mass. It is more preferable that
本実施形態で用いる粘着基剤は、パップ剤の粘着基剤及びプラスター剤の粘着基剤のいずれであってもよい。まず、パップ剤の粘着基剤について説明する。 The adhesive base used in the present embodiment may be any one of a sticking adhesive base and a plaster adhesive base. First, the adhesive base of the poultice will be described.
パップ剤の粘着基剤は、β−グルカンのほかに、水を含有し、かつ、天然高分子、セルロース系ポリマー及びその塩、アクリル系ポリマー及びその塩、並びに、ビニル系ポリマー及びその塩からなる群から選択される一種以上の水溶性高分子を更に含有している。 The adhesive base of the poultice contains water in addition to β-glucan, and comprises a natural polymer, a cellulose polymer and a salt thereof, an acrylic polymer and a salt thereof, and a vinyl polymer and a salt thereof. It further contains one or more water-soluble polymers selected from the group.
水溶性高分子の具体例は以下のとおりである。天然高分子としては、アガロース、アルギン酸ナトリウム、アラビアガム、カラギーナン、グァガム、ローカストビーンガム、ペクチン、トラガント、デンプン、プルラン、キサンタンガム、デキストリン、ゼラチン、カゼインが挙げられる。セルロース系ポリマーとしては、エチルセルロース、カルボキシメチルセルロース、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、メチルセルロース、ニトロセルロース、カチオン化セルロースが挙げられる。アクリル系ポリマーとしては、ポリアクリル酸、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリアクリルアミド、ポリアクリルアミド/アクリレート共重合体が挙げられる。ビニル系ポリマーとしては、ポリビニルピロリドン、ポリビニルアルコール、ビニルピロリドン、ポリビニルピロリドン/ビニルアルコール共重合体が挙げられる。また、ポリエチレンオキサイド、ポリビニルエーテル、メトキシエチレン無水マレイン酸共重合体、イソブチレン無水マレイン酸共重合体、N−ビニルアセトアミド、N−ビニルアセトアミドとアクリル酸及び/又はアクリル酸塩共重合体等も挙げられる。 Specific examples of the water-soluble polymer are as follows. Examples of natural polymers include agarose, sodium alginate, gum arabic, carrageenan, gua gum, locust bean gum, pectin, tragacanth, starch, pullulan, xanthan gum, dextrin, gelatin, and casein. Examples of the cellulose polymer include ethyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose sodium, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl cellulose, nitrocellulose, and cationized cellulose. Examples of the acrylic polymer include polyacrylic acid, sodium polyacrylate, carboxyvinyl polymer, polyacrylamide, and polyacrylamide / acrylate copolymer. Examples of the vinyl polymer include polyvinyl pyrrolidone, polyvinyl alcohol, vinyl pyrrolidone, and polyvinyl pyrrolidone / vinyl alcohol copolymer. In addition, polyethylene oxide, polyvinyl ether, methoxyethylene maleic anhydride copolymer, isobutylene maleic anhydride copolymer, N-vinylacetamide, N-vinylacetamide and acrylic acid and / or acrylate copolymer, and the like are also included. .
これらの中でも、β−グルカンの粘着力増強の観点からは、パップ剤の粘着基剤に含有される水溶性高分子は、ポリアクリル酸及びその塩、ポリビニルアルコール、ポリビニルピロリドン、ポリ−N−メチルビニルアセトアミド、カルボキシメチルセルロース及びその塩、ヒドロキシエチルセルロース、並びに、ヒドロキシプロピルセルロースからなる群から選択される一種以上の水溶性高分子であることが好ましい。 Among these, from the viewpoint of enhancing the adhesive strength of β-glucan, the water-soluble polymer contained in the adhesive base of the poultice is polyacrylic acid and a salt thereof, polyvinyl alcohol, polyvinyl pyrrolidone, poly-N-methyl. One or more water-soluble polymers selected from the group consisting of vinylacetamide, carboxymethylcellulose and salts thereof, hydroxyethylcellulose, and hydroxypropylcellulose are preferred.
特に、パップ剤の粘着基剤は、粘着基剤全質量を基準として、0.1〜15質量%のβ−グルカンと、0.1〜40質量%のポリアクリル酸及び/又はその塩と、0.1〜20質量%のポリビニルアルコールと、を含有していることが好ましい。かかる組成の粘着基剤は、β−グルカンの粘着力を増強することが可能であり、使用感に優れ、充分な粘着力を有する貼付剤を得ることができる。 In particular, the adhesive base of the poultice is based on the total mass of the adhesive base, 0.1 to 15% by mass of β-glucan, 0.1 to 40% by mass of polyacrylic acid and / or a salt thereof, It is preferable to contain 0.1-20 mass% polyvinyl alcohol. The adhesive base having such a composition can enhance the adhesive strength of β-glucan, and can provide a patch having excellent use feeling and sufficient adhesive strength.
パップ剤の粘着基剤は、上記成分のほか薬物を含んでいてもよい。粘着基剤に薬物(薬効成分)を配合することにより、薬効を発揮し、かつ使用感及び粘着性に優れた貼付剤とすることが可能である。粘着基剤に配合する薬物は、薬学的効果を有するものであれば特に限定はされないが、例えば、消炎鎮痛剤(インドメタシン、ケトプロフェン、フルルビプロフェン、フェルビナク、ケトロラク、ジクロフェナクナトリウム等)、制吐剤(塩酸グラニセトロン、塩酸アザセトロン、塩酸オンダンセトロン、塩酸ラモセトロン等)、ホルモン剤(エストラジオール、エストロン、エストリオール、エキリン、エキレニン、プロゲステロン、カプロン酸ヒドロキシプロゲステロン、酢酸メドロキシプロゲステロン、ジドロゲステロン、酢酸クロルマジノン、エチステロン、ジメチステロン、ノルエチステロン、酢酸ノルエチステロン、エナント酸ノルエチステロン、酢酸エチノジオール、酢酸メゲストロール、アリルエストレノール等)、頻尿治療剤(塩酸オキシブチニン等)、Ca拮抗剤(ニフェジピン、ニゾルジピン、ニカルジピン、ニトレジピン等)、コルチコステロイド類(ヒドロコルチゾン、プレドニゾロン、プロピオン酸クロベタゾール等)、催眠鎮静剤(フェノバルビタール、トリアゾラム、ニトラゼパム、ロラゼパム等)、精神安定剤(フルフェナジン、ジアゼパム、クロルプロマジン等)、抗高血圧剤(クロニジン、塩酸クロニジン、ピンドロール、プロプラノロール、ニトレンジピン、メトプロロール等)、降圧利尿剤(ハイドロサイアザイド等)、抗生物質(ペニシリン、テトラサイクリン、エリスロマイシン、クロラムフェニコール等)、麻酔剤(リドカイン、塩酸ジブカイン、アミノ安息香酸エチル等)、抗菌性物質(塩酸ベンザルコニウム、クロトリマゾール等)、ビタミン剤(ビタミンA等)、抗てんかん剤(ニトラゼパム等)、冠血管拡張剤(ニトログリセリン、硝酸イソソルビド等)、抗ヒスタミン剤(ジフェンヒドラミン、クロルフェニラミン等)、鎮咳剤(塩酸ツロブテロール、サルブタモール、フマル酸ケトチフェン、トラニラスト、塩酸イソプロテレノロール等)、抗鬱剤(塩酸クロミプラミン、塩酸アミトリプチリン等)、脳循環改善剤(メシル酸ジヒドロエルゴトキシン、イフェンプロジル等)、抗腫瘍剤(5−フルオロウラシル等)、筋弛緩剤(エペリゾン、ダントロレン等)、鎮痛剤(フェンタニール、モルヒネ等)、ポリペプチド系のホルモン剤(黄体形成ホルモン放出ホルモン(LH−RH)、甲状腺刺激ホルモン放出ホルモン(TRH)等)、末梢血管拡張剤、免疫調節剤(ポリサッカライド類、オーラノフィン、ロベンザリット等)、利胆剤(ウルソデスオキシコール酸等)、利尿剤(ヒドロフルメチアジド等)、糖尿病用剤(トルブタミド等)、痛風治療剤(コルヒチン等)、抗パーキンソン剤(アマンタジン、レボドパ等)、抗めまい剤(ジフェニドール、ベタヒスチン等)などの薬物が使用できる。 The adhesive base of the poultice may contain a drug in addition to the above components. By blending a drug (medicinal component) with the adhesive base, it is possible to obtain a patch exhibiting medicinal effects and having excellent usability and adhesiveness. The drug to be blended in the adhesive base is not particularly limited as long as it has a pharmaceutical effect. For example, anti-inflammatory analgesics (indomethacin, ketoprofen, flurbiprofen, felbinac, ketorolac, diclofenac sodium, etc.), antiemetics (Granisetron hydrochloride, azasetron hydrochloride, ondansetron hydrochloride, ramosetron hydrochloride, etc.), hormonal agents (estradiol, estrone, estriol, echirin, echilenin, progesterone, hydroxyprogesterone caproate, medroxyprogesterone acetate, didrogesterone acetate, chlormadinone acetate, ethisterone, Dimethisterone, norethisterone, norethisterone acetate, norethisterone enanthate, ethinodiol acetate, megestrol acetate, allylestrenol, etc.), frequent urination Agents (oxybutynin hydrochloride, etc.), Ca antagonists (nifedipine, nisoldipine, nicardipine, nitredipine, etc.), corticosteroids (hydrocortisone, prednisolone, clobetasol propionate, etc.), hypnotic sedatives (phenobarbital, triazolam, nitrazepam, lorazepam, etc.) Tranquilizers (fluphenazine, diazepam, chlorpromazine, etc.), antihypertensive agents (clonidine, clonidine hydrochloride, pindolol, propranolol, nitrendipine, metoprolol, etc.), antihypertensive diuretics (hydrothiazide, etc.), antibiotics (penicillin, tetracycline, erythromycin) , Chloramphenicol), anesthetics (lidocaine, dibucaine hydrochloride, ethyl aminobenzoate, etc.), antibacterial substances (benzalkonium hydrochloride, clotrimazo) ), Vitamins (such as vitamin A), antiepileptics (such as nitrazepam), coronary vasodilators (such as nitroglycerin and isosorbide nitrate), antihistamines (such as diphenhydramine and chlorpheniramine), antitussives (tulobuterol hydrochloride, salbutamol, Ketotifen fumarate, tranilast, isoproterenol hydrochloride, etc.), antidepressants (clomipramine hydrochloride, amitriptyline hydrochloride, etc.), cerebral circulation improvers (dihydroergotoxine mesylate, ifenprodil, etc.), antitumor agents (5-fluorouracil, etc.), muscle Relaxants (eperisone, dantrolene, etc.), analgesics (fentanyl, morphine, etc.), polypeptide hormones (luteinizing hormone releasing hormone (LH-RH), thyroid stimulating hormone releasing hormone (TRH), etc.), peripheral vasodilation Agent, immunity Regulators (polysaccharides, auranofin, lobanzarit, etc.), biliary (ursodesoxycholic acid, etc.), diuretics (hydroflumethiazide, etc.), diabetics (tolbutamide, etc.), gout treatments (colchicine, etc.) ), Anti-Parkinson agents (amantadine, levodopa, etc.), anti-vertigo agents (difenidol, betahistine, etc.) and the like can be used.
配合目的によって異なるが、通常は、粘着基剤の全質量を基準として0.1〜10質量%の薬物を配合するのが好ましい。また、これらの薬物は、相互作用による不都合が生じない場合には、必要に応じて2種類以上の薬物を配合することも可能である。 Usually, it is preferable to add 0.1 to 10% by mass of the drug based on the total mass of the adhesive base, although it varies depending on the compounding purpose. In addition, these drugs can be blended with two or more kinds of drugs as required when there is no inconvenience due to interaction.
また、本発明の貼付剤を化粧用用途として用いる場合には、美白効果がある美肌成分や保湿成分等の化合物及び/又は組成物を粘着基剤に配合しても良い。美肌成分としては、例えば、アロエエキス、エイジツエキス、オレンジエキス、キイチゴエキス、キウイエキス、クワエキス、キューカンバーエキス、クチナシエキス、カミツレエキス、サンザシエキス、セイヨウネズエキス、タイソウエキス、デュークエキス、トマトエキス、ヘチマエキス、サクシネルケフィラン、マレイルケフィラン、麦芽根エキス、バラエキス、コラーゲン、セラミド、スクワラン、ヒアルロン酸、アラントイン、マロニエエキス、水溶性プラセンタエキス、ビタミン類、コウジ酸などが挙げられる。また、保湿成分としては、例えば、アシル化ケフィラン水溶液、麦芽エキス、尿素、グリコール類等が挙げられる。 In addition, when the patch of the present invention is used as a cosmetic application, a compound and / or composition such as a skin-beautifying component or a moisturizing component having a whitening effect may be added to the adhesive base. Examples of skin-beautifying ingredients include aloe extract, age extract, orange extract, raspberry extract, kiwi extract, mulberry extract, cucumber extract, gardenia extract, chamomile extract, hawthorn extract, Atlantic rat extract, tiso extract, duke extract, tomato extract, loofah extract , Succinyl kefiran, maleil kefiran, malt root extract, rose extract, collagen, ceramide, squalane, hyaluronic acid, allantoin, marronnier extract, water-soluble placenta extract, vitamins, kojic acid and the like. Moreover, as a moisturizing component, acylated kefiran aqueous solution, malt extract, urea, glycols etc. are mentioned, for example.
更に、パップ剤の粘着基剤には、必要に応じて、酸化防止剤、架橋剤、防腐剤、粘着付与剤、溶解剤、色素、香料、紫外線吸収剤、無機充填剤及びpH調整剤等を粘着剤層に配合することができる。これらの成分として、貼付剤において通常用いられている物質を用いることが可能であるが、具体的には以下のとおりである。 Furthermore, the adhesive base of the poultice agent may contain an antioxidant, a crosslinking agent, an antiseptic, a tackifier, a solubilizer, a dye, a fragrance, an ultraviolet absorber, an inorganic filler, a pH adjuster, etc. It can mix | blend with an adhesive layer. As these components, substances usually used in patches can be used. Specific examples are as follows.
酸化防止剤としては、例えば、アスコルビン酸、没食子酸プロピル、ブチルヒドロキシアニソール、ジブチルヒドロキシトルエン、ノルジヒドログアヤレチン酸、トコフェロール、酢酸トコフェロール、天然ビタミンE、亜硝酸ナトリウム、及び亜硝酸水素ナトリウム等が挙げられる。 Examples of antioxidants include ascorbic acid, propyl gallate, butylhydroxyanisole, dibutylhydroxytoluene, nordihydroguaiaretic acid, tocopherol, tocopherol acetate, natural vitamin E, sodium nitrite, and sodium hydrogen nitrite. Can be mentioned.
架橋剤としては、例えば、水難溶性アルミニウム化合物、多官能性エポキシ化合物、アミノ樹脂、フェノール樹脂、エポキシ樹脂、アルキド樹脂、不飽和ポリエステル等の熱硬化性樹脂、イソシアネート化合物、ブロックイソシアネート化合物、有機系架橋剤、金属又は金属化合物等の無機系架橋剤が挙げられる。これらは、1種を単独で又は2種以上を組み合わせて用いることができる。 Examples of the crosslinking agent include a water-insoluble aluminum compound, a polyfunctional epoxy compound, an amino resin, a phenol resin, an epoxy resin, an alkyd resin, and an unsaturated polyester thermosetting resin, an isocyanate compound, a blocked isocyanate compound, and an organic crosslinking. Inorganic crosslinking agents such as agents, metals or metal compounds. These can be used alone or in combination of two or more.
防腐剤としては、例えば、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチル、ソルビン酸、及びデヒドロ酢酸等が挙げられる。 Examples of the preservative include ethyl paraoxybenzoate, propyl paraoxybenzoate, butyl paraoxybenzoate, sorbic acid, and dehydroacetic acid.
粘着付与剤としては、例えば、カゼイン、プルラン、デキストラン、アルギン酸ソーダ、可溶性デンプン、カルボキシデンプン、デキストリン、カルボキシメチルセルロース、カルボキシメチルセルロースナトリウム、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ポリビニールアルコール、ポリエチレンオキサイド、ポリアクリルアミド、ポリアクリル酸、ポリビニルピロリドン、カルボキシビニルポリマー、ポリビニルエーテル、ポリマレイン酸共重合体、メトキシエチレン無水マレイン酸共重合体、イソブチレン無水マレイン酸共重合体、ポリエチレンイミン、ポリビニールアルコール部分ケン化物、ヒドロキシプロピルメチルセルロース、キサンタンガム、N−ビニルアセトアミド等が挙げられる。 Examples of tackifiers include casein, pullulan, dextran, sodium alginate, soluble starch, carboxy starch, dextrin, carboxymethyl cellulose, sodium carboxymethyl cellulose, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, polyvinyl alcohol, polyethylene oxide, polyacrylamide, polyacrylamide. Acrylic acid, polyvinylpyrrolidone, carboxyvinyl polymer, polyvinyl ether, polymaleic acid copolymer, methoxyethylene maleic anhydride copolymer, isobutylene maleic anhydride copolymer, polyethyleneimine, polyvinyl alcohol partially saponified product, hydroxypropylmethylcellulose, Examples include xanthan gum and N-vinylacetamide.
溶解剤としては、例えば、セバシン酸ジエチル、N−メチル−2−ピロリドン、サリチル酸メチル、サリチル酸グリコール、トリアセチン、オレイルアルコール、ベンジルアルコール、ミリスチン酸イソプロピル、アジピン酸ジイソプロピル、クロタミトン、ハッカ油、ツバキ油、ヒマシ油、及びオリーブ油等が挙げられる。 Examples of the solubilizer include diethyl sebacate, N-methyl-2-pyrrolidone, methyl salicylate, glycol salicylate, triacetin, oleyl alcohol, benzyl alcohol, isopropyl myristate, diisopropyl adipate, crotamiton, mint oil, camellia oil, castor oil And oil and olive oil.
色素としては、例えば、赤色2号(アマランス)、赤色3号(エリスロシン)、赤色102号(ニューコクシン)、赤色104号の(1)(フロキシンB)、赤色105号の(1)(ローズベンガル)、赤色106号(アシッドレッド)、黄色4号(タートラジン)、黄色5号(サンセットエローFCF)、緑色3号(ファストグリーンFCF)、青色1号(ブリリアントブルーFCF)、青色2号(インジゴカルミン)等が挙げられる。 Examples of pigments include Red No. 2 (Amaranth), Red No. 3 (Erythrosin), Red No. 102 (New Coxin), Red No. 104 (1) (Phloxine B), Red No. 105 (1) (Rose) Bengal), Red 106 (Acid Red), Yellow 4 (Tartrazine), Yellow 5 (Sunset Yellow FCF), Green 3 (Fast Green FCF), Blue 1 (Brilliant Blue FCF), Blue 2 ( Indigo carmine) and the like.
香料としては、例えば、ハッカ油、ケイヒ油、チョウジ油、ウイキョウ油、ヒマシ油、テレピン油、ユーカリ油、オレンジ油、ラベンダー油、レモン油、ローズ油、レモングラス油等やローズマリー、セージ等の植物抽出物等が挙げられる。 Examples of fragrances include mint oil, cinnamon oil, clove oil, fennel oil, castor oil, turpentine oil, eucalyptus oil, orange oil, lavender oil, lemon oil, rose oil, lemongrass oil, rosemary, sage, etc. A plant extract etc. are mentioned.
紫外線吸収剤としては、例えば、パラアミノ安息香酸、パラアミノ安息香酸エステル、パラジメチルアミノ安息香酸アミル、サリチル酸エステル、アントラニル酸メンチル、ウンベリフェロン、エスクリン、ケイ皮酸ベンジル、シノキサート、グアイアズレン、ウロカニン酸、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン、ジオキシベンゾン、オクタベンゾン、ジヒドロキシジメトキシベンゾフェノン、スリソベンゾン、ベンゾレソルシノール、オクチルジメチルパラアミノベンゾエート、エチルヘキシルパラメトキシサイナメート、及びブチルメトキシジベンゾイルメタン等が挙げられる。 Examples of the ultraviolet absorber include paraaminobenzoic acid, paraaminobenzoic acid ester, amyl paradimethylaminobenzoic acid, salicylic acid ester, menthyl anthranilate, umbelliferone, esculin, benzyl cinnamate, cinoxalate, guaiazulene, urocanic acid, 2 -(2-hydroxy-5-methylphenyl) benzotriazole, 4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone, dioxybenzone, octabenzone, dihydroxydimethoxybenzophenone, soribenzone, benzoresorcinol, octyldimethylparaaminobenzoate, ethylhexylpara Examples thereof include methoxycynamate and butylmethoxydibenzoylmethane.
無機充填剤としては、例えば、炭酸カルシウム、炭酸マグネシウム、ケイ酸塩(例えば、ケイ酸アルミニウム、ケイ酸マグネシウム等)、ケイ酸、硫酸バリウム、硫酸カルシウム、亜鉛酸カルシウム、酸化亜鉛、酸化チタン等が挙げられる。 Examples of the inorganic filler include calcium carbonate, magnesium carbonate, silicate (eg, aluminum silicate, magnesium silicate, etc.), silicic acid, barium sulfate, calcium sulfate, calcium zincate, zinc oxide, titanium oxide, and the like. Can be mentioned.
pH調整剤としては、例えば、酢酸、蟻酸、乳酸、酒石酸、シュウ酸、安息香酸、グリコール酸、リンゴ酸、クエン酸、塩酸、硝酸、硫酸、水酸化ナトリウム、水酸化カルシウム、メチルアミン、エチルアミン、プロピルアミン、ジメチルアミン、ジエチルアミン、ジプロピルアミン、トリメチルアミン、トリエチルアミン、トリプロピルアミン、モノメタノールアミン、モノエタノールアミン、モノプロパノールアミン、ジメタノールアミン、ジエタノールアミン、ジプロパノールアミン、トリメタノールアミン、トリエタノールアミン、トリプロパノ−ルアミン、クエン酸バッファー、リン酸バッファー、グリシンバッファー、酢酸バッファーその他の緩衝液等が挙げられる。 Examples of the pH adjuster include acetic acid, formic acid, lactic acid, tartaric acid, oxalic acid, benzoic acid, glycolic acid, malic acid, citric acid, hydrochloric acid, nitric acid, sulfuric acid, sodium hydroxide, calcium hydroxide, methylamine, ethylamine, Propylamine, dimethylamine, diethylamine, dipropylamine, trimethylamine, triethylamine, tripropylamine, monomethanolamine, monoethanolamine, monopropanolamine, dimethanolamine, diethanolamine, dipropanolamine, trimethanolamine, triethanolamine, Examples include tripropanolamine, citrate buffer, phosphate buffer, glycine buffer, acetate buffer, and other buffer solutions.
以上、パップ剤の粘着基剤について説明を行ったが、本発明の貼付剤はプラスター剤の粘着基剤を用いてもよい。以下にプラスター剤の粘着基剤について説明する。 While the adhesive base of the poultice has been described above, the adhesive base of the present invention may use a plaster adhesive base. The plaster adhesive base will be described below.
プラスター剤の粘着基剤は粘着剤を含有し、必要に応じて粘着付与剤及び軟化剤等を含有してもよい。粘着剤としては、粘着性に優れ、薬物の放出性に優れることから、(メタ)アクリル酸エステルをモノマー単位として含む重合体を含有するアクリル系粘着剤、スチレンブロック共重合体を含有するスチレンブロック共重合体系粘着剤又はアクリル系粘着剤とスチレンブロック共重合体系粘着剤とを含有する粘着剤等が挙げられる。 The adhesive base of the plaster agent contains an adhesive, and may contain a tackifier and a softener as necessary. As an adhesive, it is excellent in adhesiveness and drug release, so an acrylic adhesive containing a polymer containing (meth) acrylic acid ester as a monomer unit, a styrene block containing a styrene block copolymer Examples thereof include an adhesive containing a copolymer adhesive or an acrylic adhesive and a styrene block copolymer adhesive.
アクリル系粘着剤としては、(メタ)アクリル酸、(メタ)アクリル酸−2−エチルヘキシル、(メタ)アクリル酸メチル、(メタ)アクリル酸ブチル、(メタ)アクリル酸ヒドロキシエチル等の(メタ)アクリルモノマーの少なくとも一種を、貼付剤の使用温度で粘着性を発揮するモノマー比で重合又は共重合させた粘着剤が挙げられる。 Examples of acrylic pressure-sensitive adhesives include (meth) acrylic acid such as (meth) acrylic acid, (meth) acrylic acid-2-ethylhexyl, methyl (meth) acrylate, butyl (meth) acrylate, and hydroxyethyl (meth) acrylate. Examples thereof include an adhesive obtained by polymerizing or copolymerizing at least one monomer at a monomer ratio that exhibits adhesiveness at the temperature at which the patch is used.
アクリル系粘着剤は、高Tgモノマー(単独重合したときにガラス転移点が室温より高いモノマー)と低Tgモノマー(単独重合したときにガラス転移点が室温未満のモノマー)とを組み合わせた共重合体が好ましい。高Tgモノマーとしては、極性で高接着性に貢献する(メタ)アクリル酸が好適であり、低Tgモノマーとしては、アルキル基の炭素数が4〜12(好ましくは、4〜8)の(メタ)アクリル酸エステル(アルキル基の水素原子が水酸基で置換されていてもよい)が好適である。 Acrylic adhesive is a copolymer that combines a high Tg monomer (a monomer having a glass transition point higher than room temperature when homopolymerized) and a low Tg monomer (a monomer having a glass transition point below room temperature when homopolymerized). Is preferred. As the high Tg monomer, (meth) acrylic acid that is polar and contributes to high adhesion is suitable, and as the low Tg monomer, an alkyl group having 4 to 12 carbon atoms (preferably 4 to 8) (meth) Acrylic acid esters (wherein the hydrogen atom of the alkyl group may be substituted with a hydroxyl group) are preferred.
アクリル系粘着剤としては、アクリル酸−2−エチルヘキシル・酢酸ビニル共重合体、アクリル酸−2−エチルヘキシル・酢酸ビニル・アクリル酸共重合体、アクリル酸−2−エチルヘキシル・酢酸ビニル・アクリル酸ヒドロキシエチル共重合体、アクリル酸−2−エチルヘキシル・酢酸ビニル・アクリル酸ヒドロキシエチル・アクリル酸共重合体、アクリル酸−2−エチルヘキシル・メタクリル酸−2−エチルヘキシル・メタクリル酸ドデシル共重合体等が好ましく、特に、アクリル酸−2−エチルヘキシル・酢酸ビニル共重合体、アクリル酸−2−エチルヘキシル・酢酸ビニル・アクリル酸共重合体が好ましい。 Acrylic adhesives include: 2-ethylhexyl acrylate / vinyl acetate copolymer, 2-ethylhexyl acrylate / vinyl acetate / acrylic acid copolymer, 2-ethylhexyl acrylate / vinyl acetate / hydroxyethyl acrylate Preferred are copolymers, 2-ethylhexyl acrylate / vinyl acetate / hydroxyethyl acrylate / acrylic acid copolymer, 2-ethylhexyl acrylate / -2-ethylhexyl methacrylate / dodecyl methacrylate copolymer, etc. 2-ethylhexyl acrylate / vinyl acetate copolymer and 2-ethylhexyl acrylate / vinyl acetate / acrylic acid copolymer are preferable.
スチレンブロック共重合体としては、スチレン−イソプレン−スチレンブロックコポリマー(SIS)、スチレン−ブタジエン−スチレンブロックコポリマー(SBS)、スチレン−エチレン−ブチレン−スチレンブロックコポリマー(SEBS)又はスチレン−エチレン−プロピレン−スチレンブロックコポリマー(SEPS)等が挙げられ、特にスチレン−イソプレン−スチレンブロックコポリマー(SIS)が好ましい。スチレンブロック共重合体系粘着剤は通常これらのスチレンブロック共重合体と以下に述べる粘着付与剤とを必須成分として含む。 Styrene block copolymers include styrene-isoprene-styrene block copolymer (SIS), styrene-butadiene-styrene block copolymer (SBS), styrene-ethylene-butylene-styrene block copolymer (SEBS) or styrene-ethylene-propylene-styrene. Examples thereof include block copolymers (SEPS), and styrene-isoprene-styrene block copolymers (SIS) are particularly preferable. A styrene block copolymer-based pressure-sensitive adhesive usually contains these styrene block copolymers and a tackifier described below as essential components.
アクリル系粘着剤とブロック共重合体系粘着剤とを含有する粘着剤としては、上記のいずれの組み合わせも可能であるが、SISとアクリル酸−2−エチルヘキシル・酢酸ビニル・アクリル酸共重合体を混合した粘着剤が特に好ましい。 Any combination of the above can be used as an adhesive containing an acrylic adhesive and a block copolymer adhesive, but SIS and 2-ethylhexyl acrylate / vinyl acetate / acrylic acid copolymer are mixed. Particularly preferred is the adhesive.
粘着付与剤としては、脂環族飽和炭化水素樹脂、ロジン又はロジン誘導体(例えば、ロジンのグリセリンエステル、水添ロジン、水添ロジンのグリセリンエステル又はロジンのペンタエリスリトールエステル等)、テルペン樹脂、石油樹脂又はマレイン酸レジン等が挙げられる。これらの中でも特に、脂環族飽和炭化水素樹脂、水添ロジンのグリセリンエステルが好適である。これらの粘着付与剤は、1種類を単独で用いても2種類以上を組み合わせて用いてもよい。 Examples of tackifiers include alicyclic saturated hydrocarbon resins, rosins or rosin derivatives (eg, rosin glycerin ester, hydrogenated rosin, hydrogenated rosin glycerin ester or rosin pentaerythritol ester), terpene resins, petroleum resins Or a maleic acid resin etc. are mentioned. Among these, alicyclic saturated hydrocarbon resins and glycerin esters of hydrogenated rosin are particularly preferable. These tackifiers may be used alone or in combination of two or more.
軟化剤としては、石油系オイル(例えばパラフィン系プロセスオイル、ナフテン系プロセスオイル又は芳香族系プロセスオイル等)、スクワラン、スクワレン、植物系オイル(例えば、アーモンド油、オリーブ油、ツバキ油、ひまし油、トール油又はラッカセイ油等)、オレフィン酸、シリコンオイル、二塩基酸エステル(例えばジブチルフタレート又はジオクチルフタレート等)、液状ゴム(例えばポリブテン又は液状イソプレンゴム等)、液状脂肪酸エステル(ミリスチン酸イソプロピル、ラウリン酸ヘキシル、セバシン酸ジエチル又はセバシン酸イソプロピル等)、ジエチレングリコール、ポリエチレングリコール、サリチル酸グリコール、プロピレングリコール、ジプロピレングリコール、トリアセチン、クエン酸トリエチル又はクロタミトン等が挙げられる。これらの中でも特に、流動パラフィン及び/又はミリスチン酸イソプロピルは皮膚への適度な付着性を付与できることから好適である。これらの軟化剤は、1種類を単独で用いても2種類以上を組み合わせて用いてもよい。 Softeners include petroleum oils (eg paraffinic process oil, naphthenic process oil or aromatic process oil), squalane, squalene, vegetable oils (eg almond oil, olive oil, camellia oil, castor oil, tall oil) Or peanut oil, etc.), olefinic acid, silicone oil, dibasic acid ester (such as dibutyl phthalate or dioctyl phthalate), liquid rubber (such as polybutene or liquid isoprene rubber), liquid fatty acid ester (isopropyl myristate, hexyl laurate, Diethyl sebacate or isopropyl sebacate), diethylene glycol, polyethylene glycol, salicylate glycol, propylene glycol, dipropylene glycol, triacetin, triethyl citrate Tamiton, and the like. Among these, liquid paraffin and / or isopropyl myristate are preferable because they can impart appropriate adhesion to the skin. These softeners may be used alone or in combination of two or more.
更に、プラスター剤の粘着基剤は、前述した薬物、美肌成分及び保湿成分を含有していてもよい。また、プラスター剤の粘着基剤は、必要に応じて、酸化防止剤、架橋剤、防腐剤、溶解剤、色素、香料、紫外線吸収剤、無機充填剤及びpH調整剤等を含有していてもよい。これらの成分の具体例は、パップ剤の粘着基剤で挙げた具体例と同様である。 Furthermore, the adhesive base of the plaster agent may contain the aforementioned drug, skin beautifying component and moisturizing component. Moreover, the adhesive base of the plaster agent may contain an antioxidant, a crosslinking agent, an antiseptic, a solubilizer, a dye, a fragrance, an ultraviolet absorber, an inorganic filler, a pH adjuster, and the like as necessary. Good. Specific examples of these components are the same as the specific examples given for the adhesive base of the poultice.
上述した成分を含有する粘着基剤から形成される粘着剤層3は、支持体2上に配置される。本実施形態の貼付剤1に用いられる支持体2としては、粘着剤層3を支持し得るものであれば特に制限されず、伸縮性又は非伸縮性の支持体を用いることができる。
The pressure-sensitive adhesive layer 3 formed from the pressure-sensitive adhesive base containing the components described above is disposed on the
かかる支持体としては、具体的には、ポリウレタン、ポリエステル、ポリプロピレン、ポリ酢酸ビニル、ポリ塩化ビニリデン、ポリエチレン、ポリエチレンテレフタレート、アルミニウムシート、ナイロン、アクリル、綿、レーヨン、アセテート等の合成繊維又は天然繊維、あるいはこれらの繊維を複合して織布又は不織布とした繊維シート、さらにはこれらと水蒸気透過性を有するフィルムとの複合素材からなる繊維シート等が挙げられる。 As such a support, specifically, synthetic fibers or natural fibers such as polyurethane, polyester, polypropylene, polyvinyl acetate, polyvinylidene chloride, polyethylene, polyethylene terephthalate, aluminum sheet, nylon, acrylic, cotton, rayon, acetate, Or the fiber sheet which combined these fibers into the woven fabric or the nonwoven fabric, Furthermore, the fiber sheet etc. which consist of a composite material with these and the film which has water vapor permeability are mentioned.
これらの中でも、安全性、汎用性及び伸縮性の点から、ポリエステル、ポリエチレン及び/又はポリエチレンテレフタレートからなる織布又は不織布の繊維シートが好ましく、ポリエチレンテレフタレートからなる織布又は不織布の繊維シートがより好ましい。このような繊維シートは厚みのあるものであっても、柔軟性を有し、皮膚に追従しやすく、皮膚刺激性の低いものである。さらに、このような繊維シートを用いることにより適度な自己支持性を有する貼付剤を得ることが可能である。 Among these, from the viewpoint of safety, versatility, and stretchability, a woven or non-woven fiber sheet made of polyester, polyethylene and / or polyethylene terephthalate is preferable, and a woven or non-woven fiber sheet made of polyethylene terephthalate is more preferable. . Even if such a fiber sheet is thick, it has flexibility, is easy to follow the skin, and has low skin irritation. Furthermore, it is possible to obtain a patch having an appropriate self-supporting property by using such a fiber sheet.
また、貼付剤1は、粘着剤層3上に貼着された剥離シート4を備えている。このような剥離シート4としては、例えば、ポリエチレンテレフタレート等のポリエステル、ポリ塩化ビニル、ポリ塩化ビニリデン等のフィルム、上質紙とポリオレフィンとのラミネートフィルム等が挙げられる。これらの剥離シートは、粘着剤層3と接触する側の面にシリコーン処理を施すと、貼付剤1から剥離シート4を剥離する際の作業容易性が高められるので好ましい。
The patch 1 includes a
次に、本実施形態の貼付剤1の製造方法について説明する。まず、粘着基剤を常法に従って調製する。次に、得られた粘着基剤を、支持体上に塗布して塗膜を形成させ、さらに塗膜の上に剥離シートを張り合わせる。これを室温で数日間保管し、充分に架橋させることにより粘着剤層を形成する。粘着剤層が形成された後、所定の形状に裁断することにより貼付剤が得られる。 Next, the manufacturing method of the patch 1 of this embodiment is demonstrated. First, an adhesive base is prepared according to a conventional method. Next, the obtained adhesive base is applied on a support to form a coating film, and a release sheet is laminated on the coating film. This is stored at room temperature for several days and is sufficiently crosslinked to form an adhesive layer. After the pressure-sensitive adhesive layer is formed, the patch is obtained by cutting into a predetermined shape.
以上、本発明の貼付剤の好適な実施形態、並びに本発明の貼付剤の製造方法について説明したが、本発明は上記実施形態に限定されるものではない。 As mentioned above, although preferred embodiment of the patch of this invention and the manufacturing method of the patch of this invention were demonstrated, this invention is not limited to the said embodiment.
例えば、貼付剤の形状を、円形、楕円形等の形状としてもよい。また、穴や切れ目等を施してもよい。さらに、貼付剤が使用される身体の部位に応じて適宜設計された形状とすることができる。例えば、顔に貼付できるよう、顔面の形状に裁断し、適宜目、鼻、口および顎を適当な形状に切ったものが挙げられる。 For example, the shape of the patch may be a circle or an ellipse. Moreover, you may give a hole, a cut | interruption, etc. Furthermore, it can be made into the shape designed suitably according to the site | part of the body where a patch is used. For example, it can be cut into the shape of a face so that it can be applied to the face, and the eyes, nose, mouth and chin can be cut into appropriate shapes.
また、貼付剤の製造方法において、粘着基剤を剥離シート上に塗布して粘着剤層を形成してから、支持体を粘着剤層に張り合わせてもよい。 Moreover, in the manufacturing method of a patch, after apply | coating an adhesive base on a peeling sheet and forming an adhesive layer, you may bond a support body to an adhesive layer.
本発明の貼付剤は、医薬品若しくはそれに類するパップ剤、プラスター剤、冷却シート、化粧品若しくはそれに類するパック剤等に利用することができる。 The patch of the present invention can be used for pharmaceuticals or a similar patch, plaster, cooling sheet, cosmetic or similar pack.
以下、実施例を挙げて本発明について更に詳しく説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in more detail, this invention is not limited to these Examples.
(実施例1)
1.5%のカードラン、3.5%のポリアクリル酸、2.5%のポリアクリル酸ナトリウム、1.5%のポリビニルアルコール、30.0%の濃グリセリン、0.5%のモノステアリン酸ポリエチレングリコール、0.5%の合成ケイ酸アルミニウム、0.3%のメタケイ酸アルミン酸マグネシウム、1.0%の酸化チタン、0.35%のエデト酸ナトリウム、0.3%の酒石酸、1.25%のサリチル酸グリコール、0.1%のl−メントール0.3%のdl−カンフル、1.0%の酢酸トコフェロール、残量を水という組成(%はすべて質量%を表す。)のパップ剤を常法により製造した。なお、得られたパップ剤のpHは5.08であった。
Example 1
1.5% curdlan, 3.5% polyacrylic acid, 2.5% sodium polyacrylate, 1.5% polyvinyl alcohol, 30.0% concentrated glycerin, 0.5% monostearin Polyethylene glycol acid, 0.5% synthetic aluminum silicate, 0.3% magnesium aluminate metasilicate, 1.0% titanium oxide, 0.35% sodium edetate, 0.3% tartaric acid, 1% Pap of 25% glycol salicylate, 0.1% l-menthol 0.3% dl-camphor, 1.0% tocopherol acetate, remaining amount of water (% represents mass%). The agent was prepared by a conventional method. The pH of the obtained cataplasm was 5.08.
(比較例1)
実施例1のパップ剤の組成において、カードランの代わりにゼラチンを用いた組成のパップ剤を実施例1と同様の方法により製造した。なお、得られたパップ剤のpHは5.24であった。
(Comparative Example 1)
In the composition of the cataplasm of Example 1, a cataplasm having a composition using gelatin instead of curdlan was produced in the same manner as in Example 1. In addition, pH of the obtained cataplasm was 5.24.
(試験例1)
実施例1及び比較例1のパップ剤の粘着力を測定した。粘着力の測定は、Nichiban Rolling Ball 法(「接着便覧」、高分子刊行会、第14版、p.381、1985年)に従った。すなわち、20/32インチのステンレス製ボールをパップ剤の上で転がして、ボールの転がった距離を粘着力の指標として、粘着力を測定した。
(Test Example 1)
The adhesive force of the cataplasm of Example 1 and Comparative Example 1 was measured. The adhesive strength was measured according to the Nichiban Rolling Ball method ("Adhesion Handbook", Kobunshi Shuppankai, 14th edition, p. 381, 1985). That is, a 20/32 inch stainless steel ball was rolled on a poultice, and the adhesive strength was measured using the distance the ball rolled as an index of adhesive strength.
比較例1のパップ剤の粘着力(mm)は、40.2であったのに対して、実施例1のパップ剤の粘着力は23.2であり、実施例1のパップ剤の粘着力の方が強いことが明らかとなった。 The adhesive strength (mm) of the cataplasm of Comparative Example 1 was 40.2, whereas the adhesive of the cataplasm of Example 1 was 23.2, and the adhesive of the cataplasm of Example 1 It became clear that was stronger.
(試験例2)
健常人8人に、実施例1及び比較例1のパップ剤を肘に6時間、貼付し、粘着力、膏体(粘着基剤)の軟らかさ及び香りの強さについて評価してもらった。評価は、比較例1のパップ剤を基準として、実施例1のパップ剤は何倍粘着力が強いか等の倍数の数値で評価した。各項目の評価結果を表1にまとめた。
(Test Example 2)
Eight healthy persons were allowed to apply the patch of Example 1 and Comparative Example 1 on their elbows for 6 hours, and evaluated the adhesive strength, the softness of the plaster (adhesive base) and the strength of the scent. Evaluation was based on the numerical value of multiples, such as how many times the poultice of Example 1 is stronger, with the cataplasm of Comparative Example 1 as a reference. The evaluation results for each item are summarized in Table 1.
表1に示した結果から分かるように、粘着力に関しては、すべての被験者が実施例1のパップ剤の方が粘着力が優れていると評価をした。また、膏体の軟らかさ、香りの強さについては、同等の評価又は実施例1のパップ剤の方が優れているという評価が得られた。以上の結果から、本発明の貼付剤は、使用感に優れ、かつ、充分な粘着力を有していることが確認された。 As can be seen from the results shown in Table 1, regarding the adhesive strength, all the subjects evaluated that the cataplasm of Example 1 had better adhesive strength. Moreover, about the softness of the plaster and the strength of the fragrance, the same evaluation or evaluation that the cataplasm of Example 1 was superior was obtained. From the above results, it was confirmed that the patch of the present invention was excellent in use feeling and had sufficient adhesive strength.
1…貼付剤、2…支持体、3…粘着剤層、4…剥離シート。 DESCRIPTION OF SYMBOLS 1 ... Patch, 2 ... Support body, 3 ... Adhesive layer, 4 ... Release sheet.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134121A JP4592326B2 (en) | 2004-04-28 | 2004-04-28 | Patch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004134121A JP4592326B2 (en) | 2004-04-28 | 2004-04-28 | Patch |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005314290A JP2005314290A (en) | 2005-11-10 |
JP4592326B2 true JP4592326B2 (en) | 2010-12-01 |
Family
ID=35442081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004134121A Expired - Lifetime JP4592326B2 (en) | 2004-04-28 | 2004-04-28 | Patch |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4592326B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800003872A1 (en) * | 2018-03-22 | 2019-09-22 | Dtech Soc A Responsabilita Limitata | PRODUCT FOR THERAPEUTIC TREATMENT FOR THE PREVENTION AND TREATMENT OF PATHOLOGIES OF THE ORAL CAVITY, TEETH AND DENTAL IMPLANTS |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59110617A (en) * | 1982-12-17 | 1984-06-26 | Lion Corp | Gelatin-free poultice |
JPS61165321A (en) * | 1985-01-16 | 1986-07-26 | Taisho Pharmaceut Co Ltd | Plaster |
JPH03228649A (en) * | 1990-01-31 | 1991-10-09 | Takeda Chem Ind Ltd | Chewing gum |
JPH0429927A (en) * | 1990-05-25 | 1992-01-31 | Sekisui Chem Co Ltd | Plaster |
JPH06135828A (en) * | 1992-10-23 | 1994-05-17 | Hisamitsu Pharmaceut Co Inc | Percutaneous absorption preparation |
JPH06205839A (en) * | 1992-12-04 | 1994-07-26 | Pacific Corp | Poultice for percutaneously loading-type medicine |
WO1995020330A1 (en) * | 1994-01-26 | 1995-08-03 | Japan Tobacco Inc. | Smoking article |
JPH0987173A (en) * | 1995-09-25 | 1997-03-31 | Lion Corp | Aqueous tacky adhesive composition |
JPH09143060A (en) * | 1995-11-16 | 1997-06-03 | Showa Denko Kk | Composition for water-containing gel plaster base |
JPH09208462A (en) * | 1996-02-07 | 1997-08-12 | Tsumura & Co | Autoadhesive cataplasm |
JPH11199520A (en) * | 1997-12-26 | 1999-07-27 | Lion Corp | Preparation for external use for skin |
JP2002512087A (en) * | 1998-04-22 | 2002-04-23 | アドバンスト・メディカル・ソリューションズ・リミテッド | Solid borate-diol reaction products for wounds |
JP2004123662A (en) * | 2002-10-07 | 2004-04-22 | Lion Corp | Keratin-removing sheet |
JP2005162663A (en) * | 2003-12-02 | 2005-06-23 | Asahi Denka Kogyo Kk | Base for skin |
JP2005176786A (en) * | 2003-12-22 | 2005-07-07 | Ina Food Ind Co Ltd | Curdlan containing substance, method for producing the same and curdlan solution |
-
2004
- 2004-04-28 JP JP2004134121A patent/JP4592326B2/en not_active Expired - Lifetime
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59110617A (en) * | 1982-12-17 | 1984-06-26 | Lion Corp | Gelatin-free poultice |
JPS61165321A (en) * | 1985-01-16 | 1986-07-26 | Taisho Pharmaceut Co Ltd | Plaster |
JPH03228649A (en) * | 1990-01-31 | 1991-10-09 | Takeda Chem Ind Ltd | Chewing gum |
JPH0429927A (en) * | 1990-05-25 | 1992-01-31 | Sekisui Chem Co Ltd | Plaster |
JPH06135828A (en) * | 1992-10-23 | 1994-05-17 | Hisamitsu Pharmaceut Co Inc | Percutaneous absorption preparation |
JPH06205839A (en) * | 1992-12-04 | 1994-07-26 | Pacific Corp | Poultice for percutaneously loading-type medicine |
WO1995020330A1 (en) * | 1994-01-26 | 1995-08-03 | Japan Tobacco Inc. | Smoking article |
JPH0987173A (en) * | 1995-09-25 | 1997-03-31 | Lion Corp | Aqueous tacky adhesive composition |
JPH09143060A (en) * | 1995-11-16 | 1997-06-03 | Showa Denko Kk | Composition for water-containing gel plaster base |
JPH09208462A (en) * | 1996-02-07 | 1997-08-12 | Tsumura & Co | Autoadhesive cataplasm |
JPH11199520A (en) * | 1997-12-26 | 1999-07-27 | Lion Corp | Preparation for external use for skin |
JP2002512087A (en) * | 1998-04-22 | 2002-04-23 | アドバンスト・メディカル・ソリューションズ・リミテッド | Solid borate-diol reaction products for wounds |
JP2004123662A (en) * | 2002-10-07 | 2004-04-22 | Lion Corp | Keratin-removing sheet |
JP2005162663A (en) * | 2003-12-02 | 2005-06-23 | Asahi Denka Kogyo Kk | Base for skin |
JP2005176786A (en) * | 2003-12-22 | 2005-07-07 | Ina Food Ind Co Ltd | Curdlan containing substance, method for producing the same and curdlan solution |
Also Published As
Publication number | Publication date |
---|---|
JP2005314290A (en) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4467437B2 (en) | Warm patch | |
JP4705301B2 (en) | Patch | |
TW577760B (en) | Transdermal patch with non-steroid antirheumatic agents having an acid group | |
JP4398158B2 (en) | Patch | |
US20040039356A1 (en) | Compositions for external preparations | |
JP4856808B2 (en) | Sheet patch | |
KR20020091273A (en) | Plaster | |
JP3466305B2 (en) | Dissolving agent and external preparation containing the dissolving agent | |
JP5576573B2 (en) | Patch | |
CN101686950B (en) | Poultice and process for producing the poultice | |
JP4744439B2 (en) | Patch | |
KR20210065931A (en) | functional patch | |
JP5766475B2 (en) | Patch preparation and method for producing the same | |
WO1999036061A1 (en) | Plasticizer and patch containing the plasticizer | |
WO2003062342A1 (en) | Pressure-sensitive adhesive and patch employing the same | |
JP4592326B2 (en) | Patch | |
JP3193161B2 (en) | Transdermal absorption preparation | |
JP2008094748A (en) | Cataplasm and method for producing cataplasm | |
JP2887548B2 (en) | Hydrous skin external patch with improved usability | |
WO2014171538A1 (en) | Substrate for transdermal patch and transdermal patch using same | |
JP3406188B2 (en) | Patch | |
JP2879228B2 (en) | Elastic patch | |
JP4274951B2 (en) | Taping type patch having a support using an irregular cross-section fiber | |
WO2022065430A1 (en) | Medicinal hydrous adhesive patch | |
JPH08104622A (en) | Support and application agent for external use using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070402 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100623 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100629 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100809 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100907 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100914 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130924 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4592326 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |